KELI From Inkwell, this is the Independent News Drop. It's Thursday, June 4. I'm Keli, with Hast.
KELI We start in Washington. The House voted this week to invoke the War Powers Act and direct President Trump to end US military operations against Iran. Four Republicans crossed the aisle to join Democrats. The resolution passed.
HAST And it almost certainly stops there. The Senate is not expected to take it up, and even if it did, there are not enough votes to override a veto. So the structural fact here is that the vote is real but its effect is symbolic. What it does do is put four Republican names on record, which becomes relevant the next time a vote on this comes around.
KELI Related to the wider regional picture: the US has announced a ceasefire framework between Israel and Lebanon. The framework was described as US-led. Hezbollah was not party to the talks.
HAST That absence is the detail most coverage noted but few pressed on. A ceasefire framework without the armed party that would have to observe it is, functionally, a statement of intent by governments. Whether it becomes an operational ceasefire depends entirely on what happens next. Worth watching what Hezbollah says, not just what the State Department said.
KELI Also in the region: Russian-backed officials in occupied Crimea say Ukrainian strikes killed four people and injured at least ten. Ukraine has not commented publicly on the attacks.
HAST The sourcing there is entirely from Russian-backed officials, which does not make it false, but it is the only sourcing available. That is worth keeping in mind.
KELI To the UN Security Council. Germany ran for a rotating seat and lost. Austria and Portugal took the two available seats.
HAST Al Jazeera's framing asked whether Germany's support for Israel cost it the vote. That framing is plausible, but it is not established. UN Security Council elections involve bloc negotiations, regional horse-trading, and bilateral relationships that rarely reduce to a single issue. The honest answer is we do not know the decisive factor, and the headline's question mark is doing a lot of work.
KELI Now to two stories out of Texas. First: a federal appeals court is being asked to revive the Texas Dream Act, a state law that gave eligible undocumented students in-state tuition rates at public colleges. A lower court blocked the law last year. Advocates are now asking the appeals court to let the legal challenge proceed.
HAST The structural point here is that the Texas Dream Act was a state law, passed by a Republican-controlled legislature, and it survived for more than two decades before being challenged in federal court. The fight now is not over whether undocumented students should have access to in-state tuition in principle. It is over whether a state even has the authority to grant it. That is a narrower but more consequential legal question.
KELI Second Texas story: a state law now requires cities to commission an independent audit before they can raise property tax revenue above a set threshold. More than 130 cities, most with fewer than ten thousand residents, were blocked from raising taxes last year because they had not completed the audit.
HAST The intended purpose of the law was transparency and fiscal accountability. The practical effect, at least in the first year, has been that the cities least likely to afford an outside audit are the ones most likely to need the revenue. That is not an argument against audits. It is a gap the legislation did not address.
KELI Now to a story that requires a hard shift in tone. ProPublica has published an investigation into the Old Apostolic Lutheran Church in the United States. The reporting documents child sexual abuse that went unreported to law enforcement across multiple generations, with victims, perpetrators, and enablers sometimes spanning the same families.
HAST The structural finding in the ProPublica piece is not that abuse occurred, which is tragically common across institutions. It is that the church's internal confession-and-forgiveness process was used as a substitute for reporting, and that leaders were aware of repeat offenders. The gap between institutional response and legal obligation is the story. That gap has a name in the law: mandatory reporting. Whether any prosecutions follow depends on statutes of limitations, which vary by state and which reformers have been pushing to extend for exactly this reason.
KELI Now to an entirely different kind of story. Dawa Sherpa, a Nepali mountain guide, has been found alive on Mount Everest after six days missing. He was last seen on May 29, descending from high altitude. His client reached base camp. He did not. Cleaning crews found him crawling toward base camp and brought him in.
HAST The detail worth noting is the one that usually disappears in the survival story framing: his client made it down, and Dawa Sherpa did not. That is not an accusation. It happens in high-altitude guiding. But the economic structure of Everest is that Sherpa guides are paid to ensure client safety, often at greater personal risk. That structure is not new, but it is consistently underreported relative to the survival angle.
KELI On to Bollywood. An Indian film union has dropped its boycott call against actor Ranveer Singh. The producers of the film Don 3 had filed a complaint claiming Singh's alleged departure from the project caused major financial losses. The union had backed the producers. That backing has now been withdrawn.
HAST This one is largely an internal industry dispute that became public because the union's involvement escalated it. The resolution is quiet. No findings were published, no damages announced. From the outside, it looks like a negotiation that concluded without a ruling.
KELI We close with a story that has not yet happened. Revolution Medicines is developing a drug targeting KRAS, a mutation present in most pancreatic cancers. The drug is not yet approved. Industry analysts are already discussing expanded indications, including lung and colorectal cancers that carry the same mutation.
HAST The STAT framing is notable because it is rare that coverage of a drug's potential expansion precedes approval. That happens when investors and analysts are driving the conversation as much as clinicians are. The science may well justify the optimism. Pancreatic cancer has almost no effective targeted therapies. But the gap between clinical trial results and approved, accessible treatment is real and often long. The story worth watching is not just whether the drug works but who gets it and when.
KELI That is the drop for Thursday, June 4. From Inkwell, I'm Keli.
HAST And I'm Hast. We'll be back tomorrow.